Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
MRSN Quote, Financials, Valuation and Earnings
Last price:
$29.10
Seasonality move
:
13.83%
Day range:
$29.00 - $29.14
52-week range:
$5.21 - $40.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
56.57x
P/B ratio:
57.95x
Volume:
14K
Avg. volume:
179.4K
1-year change:
-28.15%
Market cap:
$145.1M
Revenue:
$40.5M
EPS (TTM):
-$9.43
Earnings Data
Next earnings date for MRSN
Mar 03
2026
Most recent earnings per share
-$1.51
Missed by $0.62
(Nov 14/2025)
Consensus Estimate
-$0.89
(Nov 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MRSN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 | $4.9M | -- | -- | -$3.27 | -- |
| 11/14/2025 | Q3 | $13.7M | $11M | -$1.51 | -$0.89 | -$0.62 |
| 08/13/2025 | Q2 | $6.1M | $3.1M | -$4.87 | -$4.25 | -$0.62 |
| 05/15/2025 | Q1 | $6M | $2.8M | -$0.19 | -$4.85 | $4.66 |
| 03/03/2025 | Q4 | $7.7M | $16.4M | -$2.86 | -$4.19 | $1.33 |
| 11/13/2024 | Q3 | $7.6M | $12.6M | -$0.09 | -$4.63 | $4.53 |
| 08/13/2024 | Q2 | $8.7M | $2.3M | -$0.20 | -$4.58 | $4.38 |
| 05/09/2024 | Q1 | $8.3M | $9.2M | -$0.16 | -$4.60 | $4.44 |
| 02/28/2024 | Q4 | $14.8M | $10.7M | -$0.16 | -$4.83 | $4.67 |
| 11/07/2023 | Q3 | -- | $7.7M | -$0.35 | -- | -- |
| 08/08/2023 | Q2 | -- | $10.7M | -$0.47 | -- | -- |
| 05/09/2023 | Q1 | -- | $7.8M | -$0.52 | -- | -- |
| 02/28/2023 | Q4 | -- | $14.7M | -$0.44 | -- | -- |
| 11/07/2022 | Q3 | -- | $5.6M | -$0.61 | -- | -- |
| 08/08/2022 | Q2 | -- | $4.3M | -$0.55 | -- | -- |
| 05/09/2022 | Q1 | -- | $2M | -$0.59 | -- | -- |
| 02/28/2022 | Q4 | -- | $11K | -$0.68 | -- | -- |
| 11/09/2021 | Q3 | -- | $11K | -$0.63 | -- | -- |
| 08/06/2021 | Q2 | -- | $11K | -$0.59 | -- | -- |
| 05/10/2021 | Q1 | -- | $11K | -$0.50 | -- | -- |
| 02/26/2021 | Q4 | -- | $10K | -$0.42 | -- | -- |
| 11/09/2020 | Q3 | -- | $11K | -$0.33 | -- | -- |
| 08/07/2020 | Q2 | -- | $796K | -$0.33 | -- | -- |
| 05/08/2020 | Q1 | -- | $11K | -$0.35 | -- | -- |
| 02/28/2020 | Q4 | -- | $42K | -$0.34 | -- | -- |
| 11/06/2019 | Q3 | -- | $844K | -$0.35 | -- | -- |
| 08/08/2019 | Q2 | -- | $202K | -$0.36 | -- | -- |
| 05/09/2019 | Q1 | -- | $41M | $0.70 | -- | -- |
| 03/08/2019 | Q4 | -- | $1.2M | -$0.97 | -- | -- |
| 11/13/2018 | Q3 | -- | $2.2M | -$0.74 | -- | -- |
| 08/15/2018 | Q2 | -- | $4.2M | -$0.54 | -- | -- |
| 05/14/2018 | Q1 | -- | $3.1M | -$0.54 | -- | -- |
| 03/28/2018 | Q4 | -- | $3.3M | -$0.61 | -- | -- |
| 11/09/2017 | Q3 | -- | $6.3M | -$0.35 | -- | -- |
| 08/11/2017 | Q2 | -- | $3.7M | -$0.39 | -- | -- |
| 03/31/2017 | Q1 | -- | $4.3M | -$0.34 | -- | -- |
| 12/31/2016 | Q4 | -- | $12M | $1.80 | -- | -- |
| 09/30/2016 | Q3 | -- | $3.3M | -$8.34 | -- | -- |
| 06/30/2016 | Q2 | -- | $6.2M | -$5.38 | -- | -- |
| 03/31/2016 | Q1 | -- | $3.7M | -$0.23 | -- | -- |
Mersana Therapeutics, Inc. Earnings Questions
-
How Much did Mersana Therapeutics, Inc. Generate in Revenue Last Quarter?
Mersana Therapeutics, Inc. reported $11M worth of top line sales in its most recent quarter.
-
Did Mersana Therapeutics, Inc. Beat Earnings Last Quarter?
Mersana Therapeutics, Inc. announced earnings per share of -$1.51 which represents a miss of analyst forecast a -$0.89 per share.
-
Is Mersana Therapeutics, Inc. Profitable?
Mersana Therapeutics, Inc. reported $10.9M that represents $2.19 per share over the last quarter.
-
What is the Analyst Consensus for Mersana Therapeutics, Inc. EPS Next Year?
Mersana Therapeutics, Inc.'s earnings are forecast to decrease from -$14.12 per share to -$15.20 per share next year representing a decrease of -86.82%.
-
When is Mersana Therapeutics, Inc.'s Earnings Date?
Mersana Therapeutics, Inc.'s next earnings date is March 3, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
